Technical analysis of DaVita Inc. (DVA): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes.
Price Performance
| 1 month | +4.93% |
| 3 months | -19.76% |
| Year-to-date | +65.04% |
| 1 year | +57.54% |
| 3 years | +140.97% |
| 5 years | +80.18% |
| 10 years | +220.73% |
52-Week Range
| 52-week High | $247.49 |
| 52-week Low | $101.00 |
| Avg Volume (90d) | 791K |
Technical Indicators
| SMA 50 | $181.40 |
| SMA 200 | $177.01 |
| Beta | 0.92 |
| 30-day Volatility (annualised) | 38.0% |
| Price vs SMA 50 | +3.4% |
| Price vs SMA 200 | +5.9% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $113.61 | |
| 2026-01 | $109.34 | -3.8% |
| 2026-02 | $156.30 | +42.9% |
| 2026-03 | $153.69 | -1.7% |
| 2026-04 | $155.14 | +0.9% |
| 2026-05 | $194.36 | +25.3% |
| 2026-06 | $222.48 | +14.5% |
| 2026-07 | $240.09 | +7.9% |
| 2026-08 | $176.01 | -26.7% |
| 2026-09 | $174.92 | -0.6% |
| 2026-10 | $187.50 | +7.2% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2027-02-01 | $4.26 | $3.61B |
| 2026-10-29 | $3.57 | $3.52B |
| 2026-08-04 | $3.88 | $3.50B |
| 2026-05-05 | $2.41 | $3.36B |
| 2026-02-02 | $3.24 | $3.51B |
| 2025-10-29 | $3.17 | $3.43B |
| 2025-08-05 | $2.70 | $3.44B |
Price
| Price | $187.50 (closing price, October 30, 2026) |
| Market Cap | $11.8B |
| Exchange | NYSE |
| Country | US |
Valuation Ratios
| P/E Ratio | 14.72 |
| Price / Book | -20.25 |
| EV / EBITDA | 8.82 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | -22.66 |
| Current Ratio | 1.41 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 1.56 |